Literature DB >> 9612713

Kaposi's sarcoma herpesvirus/human herpesvirus 8.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9612713      PMCID： PMC7196978     

Source DB:  PubMed          Journal:  IARC Monogr Eval Carcinog Risks Hum        ISSN： 1017-1606


× No keyword cloud information.
  11 in total

1.  Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis.

Authors:  Maria Claudia Nascimento; Vanda Akico de Souza; Laura Masami Sumita; Wilton Freire; Fernando Munoz; Joseph Kim; Claudio S Pannuti; Philippe Mayaud
Journal:  J Clin Microbiol       Date:  2006-12-20       Impact factor: 5.948

2.  Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.

Authors:  Angela Nalwoga; Marjorie Nakibuule; Vickie Marshall; Wendell Miley; Nazzarena Labo; Stephen Cose; Denise Whitby; Robert Newton
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

3.  The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression.

Authors:  A K Gupta; V Ruvolo; C Patterson; S Swaminathan
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Incidence rate trends of histological subtypes of nasopharyngeal carcinoma in Hong Kong.

Authors:  L A Tse; I T-S Yu; O W-K Mang; S-L Wong
Journal:  Br J Cancer       Date:  2006-10-10       Impact factor: 7.640

5.  Cancer risks in childhood and adolescence among the offspring of immigrants to Sweden.

Authors:  Kari Hemminki; X Li
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

6.  Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba.

Authors:  L Fernandez; D Serraino; G Rezza; J Lence; R M Ortiz; T Cruz; S Vaccarella; L Sarmati; M Andreoni; S Franceschi
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

Review 7.  An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity.

Authors:  Michael J Wells; Steven Jacobson; Paul H Levine
Journal:  Infect Agent Cancer       Date:  2019-11-05       Impact factor: 2.965

8.  Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study.

Authors:  A K Richardson; B Cox; M R E McCredie; G S Dite; J-H Chang; D M Gertig; M C Southey; G G Giles; J L Hopper
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

9.  Hodgkin's lymphoma and infection: findings from a UK case-control study.

Authors:  R Newton; S Crouch; P Ansell; J Simpson; E V Willett; A Smith; C Burton; A Jack; E Roman
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

10.  Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.

Authors:  S Franceschi; L Dal Maso; M Rickenbach; J Polesel; B Hirschel; M Cavassini; A Bordoni; L Elzi; S Ess; G Jundt; N Mueller; G M Clifford
Journal:  Br J Cancer       Date:  2008-07-29       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.